A rare syndrome that affects the nervous system has been added to the list of possible side effects of AstraZeneca COVID jab.
The Medicines and Health Products Regulatory Agency (MHRA) has added Guillain-Barré syndrome as a possible side effect of the vaccine.
Guillain-Barré (GBS) is a rare autoimmune disease in which a person’s immune system damages their nerves, causing weakness and sometimes paralysis.
It mainly affects the nerves in the feet, hands and limbs, according to the NHS, and symptoms can last from a few weeks to several years. Most people make a full recovery, but some can suffer permanent nerve damage.
The syndrome was added to the list of potential side effects of AstraZeneca jab by the European Medicines Agency (EMA) last month, and now the MHRA has also added it to their list after a review of the available data.
But the syndrome falls into a category of “very rare” potential side effects, according to the government website, which means those that may affect up to one in 10,000 people.
Read more: Vast majority of Britons think MPs should wear masks in the Commons
Included in this category are blood clots, which the site says have caused “extremely rare reports,” as well as “severe nerve inflammation, which can cause paralysis and difficulty breathing (Guillain-Barré syndrome). [GBS]) “.
According to some reports, a government document revealed that up to October 13, the MHRA had received 432 reports of the syndrome with the AstraZeneca COVID vaccine, 59 following the use of the Pfizer / BioNTech vaccine and four reports related to the Moderna vaccine.
Health officials argue that vaccination is the best way to fight COVID-19, with the government urging anyone who has not received a vaccine to get one.
Government data up to October 23 shows that of the 95,226,529 Covid injections administered in the UK, 49,684,322 were first doses, an increase of 36,171 the day before.
Some 45,542,207 were second doses, an increase of 29,804.
Watch: Do Coronavirus Vaccines Affect Fertility?